(Reuters) – Synairgen Plc (SYNG.L) said Monday that his drug helped reduce the risk of serious cases in hospitalized patients with COVID-19, according to data from a trial of more than 100 people in the UK, which triggered his actions. The trial, which used interferon beta, showed that patients who …
Read More »Synairgen’s actions skyrocket when the drug shows a lower risk of serious cases of COVID-19
